Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Generation of recombinant lymphocytic choriomeningitis viruses with trisegmented genomes stably expressing two additional genes of interest.

Emonet SF, Garidou L, McGavern DB, de la Torre JC.

Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3473-8. doi: 10.1073/pnas.0900088106. Epub 2009 Feb 10.

2.

Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines.

Cheng BY, Ortiz-Riaño E, de la Torre JC, Martínez-Sobrido L.

J Virol. 2015 Jul;89(14):7373-84. doi: 10.1128/JVI.00307-15. Epub 2015 May 13.

3.

Development of live-attenuated arenavirus vaccines based on codon deoptimization.

Cheng BY, Ortiz-Riaño E, Nogales A, de la Torre JC, Martínez-Sobrido L.

J Virol. 2015 Apr;89(7):3523-33. doi: 10.1128/JVI.03401-14. Epub 2015 Jan 14.

4.

General Molecular Strategy for Development of Arenavirus Live-Attenuated Vaccines.

Iwasaki M, Ngo N, Cubitt B, Teijaro JR, de la Torre JC.

J Virol. 2015 Dec;89(23):12166-77. doi: 10.1128/JVI.02075-15. Epub 2015 Sep 23.

5.

Identification and Mechanism of Action of a Novel Small-Molecule Inhibitor of Arenavirus Multiplication.

Ngo N, Cubitt B, Iwasaki M, de la Torre JC.

J Virol. 2015 Nov;89(21):10924-33. doi: 10.1128/JVI.01587-15. Epub 2015 Aug 19. Erratum in: J Virol. 2016 Sep 15;90(18):8381.

6.

Self-association of lymphocytic choriomeningitis virus nucleoprotein is mediated by its N-terminal region and is not required for its anti-interferon function.

Ortiz-Riaño E, Cheng BY, de la Torre JC, Martínez-Sobrido L.

J Virol. 2012 Mar;86(6):3307-17. doi: 10.1128/JVI.05503-11. Epub 2012 Jan 18.

7.
8.
9.

Recombinant lymphocytic choriomeningitis virus expressing vesicular stomatitis virus glycoprotein.

Pinschewer DD, Perez M, Sanchez AB, de la Torre JC.

Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7895-900. Epub 2003 Jun 13.

11.

Envelope exchange for the generation of live-attenuated arenavirus vaccines.

Bergthaler A, Gerber NU, Merkler D, Horvath E, de la Torre JC, Pinschewer DD.

PLoS Pathog. 2006 Jun;2(6):e51. Epub 2006 Jun 2.

12.

Molecular and cell biology of the prototypic arenavirus LCMV: implications for understanding and combating hemorrhagic fever arenaviruses.

de la Torre JC.

Ann N Y Acad Sci. 2009 Sep;1171 Suppl 1:E57-64. doi: 10.1111/j.1749-6632.2009.05048.x.

PMID:
19751403
14.

Cells expressing the RING finger Z protein are resistant to arenavirus infection.

Cornu TI, Feldmann H, de la Torre JC.

J Virol. 2004 Mar;78(6):2979-83.

15.

Use of single-cycle infectious lymphocytic choriomeningitis virus to study hemorrhagic fever arenaviruses.

Rodrigo WW, de la Torre JC, Martínez-Sobrido L.

J Virol. 2011 Feb;85(4):1684-95. doi: 10.1128/JVI.02229-10. Epub 2010 Dec 1.

16.
17.

Different mechanisms of cell entry by human-pathogenic Old World and New World arenaviruses.

Rojek JM, Sanchez AB, Nguyen NT, de la Torre JC, Kunz S.

J Virol. 2008 Aug;82(15):7677-87. doi: 10.1128/JVI.00560-08. Epub 2008 May 28.

18.

Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV).

Ruiz-Jarabo CM, Ly C, Domingo E, de la Torre JC.

Virology. 2003 Mar 30;308(1):37-47.

20.

D471G mutation in LCMV-NP affects its ability to self-associate and results in a dominant negative effect in viral RNA synthesis.

Ortiz-Riaño E, Cheng BY, de la Torre JC, Martínez-Sobrido L.

Viruses. 2012 Oct 16;4(10):2137-61. doi: 10.3390/v4102137.

Supplemental Content

Support Center